Synovial Sarcoma News and Research

RSS
3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Potential new therapeutic approach developed for synovial sarcoma

Potential new therapeutic approach developed for synovial sarcoma

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

S*BIO initiates SB939 Phase 2 clinical trial for metastatic prostate cancer

S*BIO initiates SB939 Phase 2 clinical trial for metastatic prostate cancer

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

REOLYSIN shown to benefit some sarcoma patients

REOLYSIN shown to benefit some sarcoma patients

CTRC enrolls first patients in study for sarcoma

CTRC enrolls first patients in study for sarcoma